Medical Devices & Tech

OncoSec Medical

4690 Executive Drive Suite 250
San Diego, CA USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Developing novel, localized anti-cancer therapies to avert side-effects

Management Punit Dhillon, President and CEO; Caryn Peterson, Vice President, Regulatory Affairs; Brian McCluskey B.S. EE, Executive Director, Engineering; Veronica Vallejo, CPA, Vice President Finance and Controller; Ernest Kitt. Executive Director, Clinical Operations; Michael Cross, Ph.D., Chief Business Officer

Click here for Financial Data
Keywords: Oncology, metastatic cancer, melanoma, metastasis, chemotherapy, immunotherapy, dermatology, DrugDelivery, GCC Member


Updated: Jun. 09, 2019


OncoSec Medical is developing novel, localized therapies against solid tumors to overcome side effects associated with non-targeted approaches. Contemporary non-targeted approaches include surgery, wh......view more

Products / Services

OncoSec's proprietary delivery system, called the OncoSec Medical System (OMS), directly addresses this challenge of delivering the agent in a safe and effective manner by harnessing a scientific p......view more

Technology / Differentiation

OncoSec's novel solid tumor therapies consist of two main components: the first is an agent capable of selectively killing cancerous cells or stimulating the immune system to kill cancerous cells; the...view more

Analyst Coverage